Advertisement
Screener

Alaunos Therapeutics, Inc. (TCRT) Form D

Alaunos Therapeutics, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2016-07-07: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-06-30; Total offering amount $120,000,000.
  • 2015-01-28: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-01-13; Total offering amount $57,500,000.
  • 2012-11-21: Federal exemption Rule 506; Types of securities offered Equity; Date of first sale 2012-11-07; Total offering amount $3,637.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2016-07-07Rule 506(b)Equity2016-06-30$120,000,000$120,000,000$01
2015-01-28Rule 506(b)Equity2015-01-13$57,500,000$57,500,000$01
2012-11-21Rule 506Equity2012-11-07$3,637$3,637$01

Similar stocks

Stock NameCountryMarket CapPE Ratio
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02